Protagenic Therapeutics, Inc.\new Research and Development Expense
Protagenic Therapeutics, Inc.\new (PTIX) reported Research and Development Expense of $109.92 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new research and development expense for the quarter ending 2026-06-30 was $109.92K, a 72.11% decline year-over-year.
- Protagenic Therapeutics, Inc.\new research and development expense for the quarter ending 2026-03-31 was $80.77K, a 90.83% decline year-over-year.
- Protagenic Therapeutics, Inc.\new research and development expense for the quarter ending 2025-12-31 was $153.79K, a 14.27% increase year-over-year.
- Protagenic Therapeutics, Inc.\new research and development expense for the quarter ending 2025-09-30 was $273.23K, a 1510.64% increase year-over-year.
- Protagenic Therapeutics, Inc.\new research and development expense for fiscal 2026 was $901.90K, a 139.39% increase from fiscal 2025.
- Protagenic Therapeutics, Inc.\new research and development expense for fiscal 2025 was $376.74K.
- Protagenic Therapeutics, Inc.\new research and development expense for fiscal 2024 was $3.84M, a 25.51% increase from fiscal 2023.
- Protagenic Therapeutics, Inc.\new research and development expense for fiscal 2023 was $3.06M, a 92.77% increase from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $109.92K 10-Q · filed 2026-08-19 | $190.69K derived: sum of 2 quarters · filed 2026-08-19 | $344.48K derived: sum of 3 quarters · filed 2026-08-19 | $617.71K derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $80.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | $234.56K derived: sum of 2 quarters · filed 2026-08-14 | $507.78K derived: sum of 3 quarters · filed 2026-08-14 | $901.90K 10-K · filed 2026-08-14 | ||||
| 2025-12-31 | $153.79K 10-Q · filed 2026-03-09 | $427.01K derived: sum of 2 quarters · filed 2026-03-09 | $821.13K 10-Q · filed 2026-03-09 | $1.70M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-09-30 | $273.23K 10-Q · filed 2025-11-26 | $667.34K 10-Q · filed 2025-11-26 | $1.55M derived: sum of 3 quarters · filed 2026-08-19 | $1.68M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | $394.11K 10-Q · filed 2026-08-19 | $1.27M derived: sum of 2 quarters · filed 2026-08-19 | $1.41M derived: sum of 3 quarters · filed 2026-08-19 | $1.43M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $880.37K 10-Q · filed 2025-05-13 | $1.01M derived: sum of 2 quarters · filed 2026-03-09 | $1.03M derived: sum of 3 quarters · filed 2026-03-09 | $376.74K 10-K · filed 2026-08-14 | ||||
| 2024-12-31 | $134.58K 10-Q · filed 2026-03-09 | $151.54K derived: sum of 2 quarters · filed 2026-03-09 | $170.68K 10-Q · filed 2026-03-09 | $3.84M 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $16.96K 10-Q · filed 2025-11-26 | $324.35K 10-Q · filed 2024-11-14 | $36.10K 10-Q · filed 2025-11-26 | $2.98M 10-Q · filed 2024-11-14 | $2.51M derived: sum of 4 quarters · filed 2025-11-26 | |||
| 2024-06-30 | $19.14K 10-QT · filed 2025-09-10 | $1.20M 10-Q · filed 2024-08-14 | $2.66M 10-Q · filed 2024-08-14 | $2.49M derived: sum of 3 quarters · filed 2025-09-10 | $3.62M derived: sum of 4 quarters · filed 2025-09-10 | |||
| 2024-03-31 | $1.46M 10-Q · filed 2025-05-13 | $2.47M derived: sum of 2 quarters · filed 2025-05-13 | $3.60M derived: sum of 3 quarters · filed 2025-05-13 | $4.27M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.14M derived: sum of 2 quarters · filed 2025-03-31 | $2.81M derived: sum of 3 quarters · filed 2025-03-31 | $3.06M 10-K · filed 2025-03-31 | $3.32M 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $1.12M 10-Q · filed 2024-11-14 | $1.80M derived: sum of 2 quarters · filed 2024-11-14 | $2.05M 10-Q · filed 2024-11-14 | $2.31M 10-Q · filed 2023-11-14 | $2.40M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $671.17K 10-Q · filed 2024-08-14 | $836.38K 10-Q · filed 2023-08-14 | $927.65K 10-Q · filed 2024-08-14 | $1.18M 10-Q · filed 2023-08-14 | $1.28M derived: sum of 3 quarters · filed 2024-08-14 | $1.78M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $348.03K 10-Q · filed 2024-05-15 | $605.55K derived: sum of 2 quarters · filed 2024-05-15 | $1.11M derived: sum of 3 quarters · filed 2024-05-15 | $1.27M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $257.52K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | $758.89K derived: sum of 2 quarters · filed 2024-05-14 | $919.40K derived: sum of 3 quarters · filed 2024-05-14 | $1.59M 10-K/A · filed 2024-05-14 | ||||
| 2022-09-30 | $501.37K 10-Q · filed 2023-11-14 | $661.88K derived: sum of 2 quarters · filed 2023-11-14 | $1.33M 10-Q · filed 2023-11-14 | $1.48M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $160.51K 10-Q · filed 2023-08-14 | $830.35K 10-Q · filed 2023-08-14 | $976.92K derived: sum of 3 quarters · filed 2023-08-14 | $1.23M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $669.84K 10-Q · filed 2023-05-15 | $816.41K derived: sum of 2 quarters · filed 2023-05-15 | $1.07M derived: sum of 3 quarters · filed 2023-05-15 | $1.21M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $146.57K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $403.85K derived: sum of 2 quarters · filed 2023-03-31 | $544.44K derived: sum of 3 quarters · filed 2023-03-31 | $1.14M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $257.28K 10-Q · filed 2022-11-14 | $397.87K derived: sum of 2 quarters · filed 2022-11-14 | $990.22K 10-Q · filed 2022-11-14 | $1.03M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $140.59K 10-Q · filed 2022-08-11 | $732.94K 10-Q · filed 2022-08-11 | $775.00K derived: sum of 3 quarters · filed 2022-08-11 | $1.31M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $592.35K 10-Q · filed 2022-05-13 | $634.41K derived: sum of 2 quarters · filed 2022-05-13 | $1.17M derived: sum of 3 quarters · filed 2022-05-13 | $1.23M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $42.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | $581.83K derived: sum of 2 quarters · filed 2022-04-07 | $633.84K derived: sum of 3 quarters · filed 2022-04-07 | $699.80K 10-K · filed 2022-04-07 | ||||
| 2020-09-30 | $539.77K 10-Q · filed 2021-11-15 | $591.78K derived: sum of 2 quarters · filed 2021-11-15 | $657.74K 10-Q · filed 2021-11-15 | $1.17M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $52.01K 10-Q · filed 2021-08-16 | $117.97K 10-Q · filed 2021-08-16 | $634.09K derived: sum of 3 quarters · filed 2021-08-16 | $665.24K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $65.96K 10-Q · filed 2021-05-17 | $582.08K derived: sum of 2 quarters · filed 2021-05-17 | $613.23K derived: sum of 3 quarters · filed 2021-05-17 | $738.50K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $516.12K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $547.27K derived: sum of 2 quarters · filed 2021-03-25 | $672.54K derived: sum of 3 quarters · filed 2021-03-25 | $807.95K 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | $31.15K 10-Q · filed 2020-11-16 | $156.42K derived: sum of 2 quarters · filed 2020-11-16 | $291.83K 10-Q · filed 2020-11-16 | $485.67K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $125.26K 10-Q · filed 2020-08-14 | $260.68K 10-Q · filed 2020-08-14 | $454.51K derived: sum of 3 quarters · filed 2020-08-14 | $617.59K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $135.41K 10-Q · filed 2020-06-18 | $329.25K derived: sum of 2 quarters · filed 2020-06-18 | $492.32K derived: sum of 3 quarters · filed 2020-06-18 | $826.18K derived: sum of 4 quarters · filed 2020-06-18 | ||||
| 2018-12-31 | $193.84K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $356.91K derived: sum of 2 quarters · filed 2020-04-29 | $690.77K derived: sum of 3 quarters · filed 2020-04-29 | $881.19K 10-K · filed 2020-04-29 | ||||
| 2018-09-30 | $163.07K 10-Q · filed 2019-11-14 | $496.93K derived: sum of 2 quarters · filed 2019-11-14 | $687.35K 10-Q · filed 2019-11-14 | $995.19K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $333.86K 10-Q · filed 2019-08-14 | $524.28K 10-Q · filed 2019-08-14 | $832.12K derived: sum of 3 quarters · filed 2019-08-14 | $982.74K derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $190.41K 10-Q · filed 2019-05-16 | $498.25K derived: sum of 2 quarters · filed 2019-05-16 | $648.87K derived: sum of 3 quarters · filed 2019-05-16 | $769.05K derived: sum of 4 quarters · filed 2019-05-16 | ||||
| 2017-12-31 | $307.84K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $458.46K derived: sum of 2 quarters · filed 2019-03-29 | $578.64K derived: sum of 3 quarters · filed 2019-03-29 | $717.45K 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | $150.62K 10-Q · filed 2018-11-08 | $270.80K derived: sum of 2 quarters · filed 2018-11-08 | $409.61K 10-Q · filed 2018-11-08 | $488.84K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $120.18K 10-Q · filed 2018-08-14 | $258.99K 10-Q · filed 2018-08-14 | $338.23K derived: sum of 3 quarters · filed 2018-08-14 | $449.05K derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $138.81K 10-Q · filed 2018-05-15 | $218.04K derived: sum of 2 quarters · filed 2018-05-15 | $328.87K derived: sum of 3 quarters · filed 2018-05-15 | $619.44K derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $79.23K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $190.05K derived: sum of 2 quarters · filed 2018-04-02 | $480.63K derived: sum of 3 quarters · filed 2018-04-02 | $417.87K 10-K · filed 2018-04-02 | $533.69K 10-K · filed 2017-04-18 | |||
| 2016-09-30 | $110.82K 10-Q · filed 2017-11-13 | $114.94K 10-Q · filed 2016-11-17 | $401.40K derived: sum of 2 quarters · filed 2017-11-13 | $338.63K 10-Q · filed 2017-11-13 | $537.66K 10-Q · filed 2016-11-17 | $640.95K derived: sum of 4 quarters · filed 2017-11-13 | ||
| 2016-06-30 | $290.58K 10-Q · filed 2017-08-08 | $374.21K 10-Q · filed 2016-08-15 | $227.81K 10-Q · filed 2017-08-08 | $422.72K 10-Q · filed 2016-08-15 | $530.13K derived: sum of 3 quarters · filed 2017-08-08 | $733.94K derived: sum of 4 quarters · filed 2017-08-08 | ||
| 2016-03-31 | $48.52K 10-Q · filed 2017-05-15 | $239.55K derived: sum of 2 quarters · filed 2017-05-15 | $443.37K derived: sum of 3 quarters · filed 2017-05-15 | $483.34K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $191.04K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-05-08 | $394.85K derived: sum of 2 quarters · filed 2017-05-08 | $434.82K derived: sum of 3 quarters · filed 2017-05-08 | $456.27K 10-K/A · filed 2017-05-08 | ||||
| 2015-09-30 | $203.81K 10-Q · filed 2016-11-17 | $243.79K derived: sum of 2 quarters · filed 2016-11-17 | $265.24K 10-Q · filed 2016-11-17 | $265.24K derived: sum of 4 quarters · filed 2016-11-17 | ||||
| 2015-06-30 | $39.98K 10-Q · filed 2016-08-15 | $61.42K 10-Q · filed 2016-08-15 | $61.42K derived: sum of 3 quarters · filed 2016-08-15 | $61.42K derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $21.45K 10-Q · filed 2016-07-25 | $0.00 10-Q · filed 2015-05-11 | $21.45K derived: sum of 2 quarters · filed 2016-07-25 | $0.00 10-Q · filed 2015-05-11 | ||||
| 2014-12-31 | $0.00 10-Q · filed 2015-02-06 | $0.00 10-Q · filed 2015-02-06 | $191.07K 8-K/A · filed 2016-07-12 | |||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | |||||||
| 2014-06-30 | $42.00K 10-K · filed 2014-10-14 | |||||||
| 2014-03-31 | $8.00K 10-Q · filed 2015-05-11 | $18.00K derived: sum of 2 quarters · filed 2015-05-11 | $29.00K 10-Q · filed 2015-05-11 | |||||
| 2013-12-31 | $10.00K 10-Q · filed 2015-02-06 | $21.00K 10-Q · filed 2015-02-06 | ||||||
| 2013-09-30 | $11.00K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |